Abeona Therapeutics Inc. (ABEO) vs Vanda Pharmaceuticals Inc. (VNDA)
A side-by-side comparison of Abeona Therapeutics Inc. and Vanda Pharmaceuticals Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
ABEO
Abeona Therapeutics Inc.
$5.01HealthcareDelayed quote: Oct 6, 2026, 4:00 PM EDT
VNDA
Vanda Pharmaceuticals Inc.
$4.52HealthcareDelayed quote: Oct 6, 2026, 4:00 PM EDT
Total return — ABEO vs VNDA
growth of $100 · dividends reinvested · last 10yABEO -96.6% (-28.7%/yr)VNDA -72.8% (-12.2%/yr)VNDA compounded faster over this window
Log scale — wide-divergence pair
ABEO VNDA
ABEO vs VNDA: by the numbers
- •ABEO is the larger company ($286M vs $272M market cap).
- •Both run net losses; VNDA's is the smaller (-127.41% vs -246.42% net margin).
- •Both shrank revenue over the past five years; VNDA's decline was smaller (-3.56% vs -10.26% CAGR).
Metrics side by side
Valuation
| Metric | ABEO | VNDA |
|---|---|---|
| P/S ratio | 11.19 | 1.26 |
| P/B ratio | 2.23 | 1.23 |
Profitability
| Metric | ABEO | VNDA |
|---|---|---|
| Gross margin | 73.68% | 92.82% |
| Operating margin | -1536.91% | -69.95% |
| Net margin | -246.42% | -127.41% |
| ROE | -49.11% | -124.83% |
| ROIC | -49.76% | -74.73% |
Growth (annualized)
| Metric | ABEO | VNDA |
|---|---|---|
| Revenue CAGR (5Y) | -10.26% | -3.56% |
| Total return CAGR (5Y) | -26.46% | -23.91% |
Frequently asked
- Which has grown faster, ABEO or VNDA?
- Neither grew: over the past five years both shrank revenue, with VNDA's decline the smaller — ABEO at a -10.26% CAGR versus VNDA at -3.56%.
- How have ABEO and VNDA total returns compared?
- Over the past 10 years, ABEO delivered -29.45% and VNDA delivered -11.90% annualized total return. Past performance doesn't predict future results.
Go deeper
Dig into the metrics
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.